China’s Minimally Invasive Brain-Computer Interface Restores Movement in Paralyzed Patient

By futureTEKnow | Editorial Team

China has achieved a major breakthrough in brain-computer interface (BCI) technology, offering new hope for people living with paralysis. Researchers at Nankai University have successfully implanted a BCI device via blood vessels, allowing a paralyzed man to regain movement in his limbs—a world first for this type of procedure.

How Does the New BCI Work?

Unlike traditional brain implants, which require opening the skull and placing electrodes directly on brain tissue (as seen with Neuralink), the Chinese team used a minimally invasive approach. Surgeons inserted a stent electrode through a vein in the patient’s neck, navigating it into the brain’s blood vessels using advanced imaging technology. .

This method reduces surgical risk and recovery time, potentially making BCI technology more accessible to a wider range of patients.

The Patient’s Journey

The recipient, a 67-year-old man, had suffered a stroke six months earlier, resulting in hemiplegia (paralysis on one side of the body). Despite intensive rehabilitation, progress was slow. After receiving the BCI implant, he began to regain movement in his paralyzed limbs, marking a significant milestone in neurorehabilitation.

How Does This Compare Globally?

FeatureChina (Nankai University)Neuralink (USA)
Implantation MethodVia blood vessels (minimally invasive)Direct brain tissue implantation
First Human Trial20252023 (FDA-approved)
Key BenefitLower surgical risk, faster recoveryDirect brain-computer connection

While Neuralink’s approach involves direct brain surgery, the Chinese method’s use of blood vessels could lower the barrier for clinical adoption and reduce complications.

Why Is This Important?

  • Minimally invasive BCI offers a safer alternative for patients who may not be candidates for open-brain surgery.

  • The technology could accelerate recovery for stroke survivors and others with paralysis, improving quality of life.

  • China’s rapid progress in BCI clinical trials positions it as a leader in next-generation neurotechnology, with regulatory frameworks already being established to support commercialization by 2028.

What’s Next for BCI in China?

China’s regulatory agencies are proactively setting guidelines and pricing structures for BCI-related medical services, signaling a commitment to bringing these innovations to market quickly. With ongoing clinical trials and further device miniaturization, the country is poised to expand access to BCI therapies for patients with paralysis, limb loss, or neurodegenerative diseases.

The bottom line: China’s minimally invasive brain-computer interface marks a transformative step in neurotechnology, showing that restoring movement to paralyzed patients is no longer just science fiction. As this technology matures, it could redefine rehabilitation and human-computer interaction for millions worldwide.

futureTEKnow covers technology, startups, and business news, highlighting trends and updates across AI, Immersive Tech, Space, and robotics.

futureTEKnow

Editorial Team

Founded in 2018, futureTEKnow is a global database dedicated to capturing the world’s most innovative companies utilizing emerging technologies across five key sectors: Artificial Intelligence (AI), immersive technologies (MR, AR, VR), blockchain, robotics, and the space industry. Initially launched as a social media platform to share technology news, futureTEKnow quickly evolved into a comprehensive resource hub, spotlighting the latest advancements and groundbreaking startups shaping the future of tech.

Trending Companies

Latest Articles